Last reviewed · How we verify
Glimepiride 2 mg
Glimepiride 2 mg is a Small molecule drug developed by Merck Sharp & Dohme LLC. It is currently FDA-approved. Also known as: Solosa, Amaryl.
Glimepiride 2 mg, marketed by Merck Sharp & Dohme LLC, is an established product in the pharmaceutical market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established market presence and long-term use. The primary risk is the potential increase in generic competition following the patent expiry in 2028.
At a glance
| Generic name | Glimepiride 2 mg |
|---|---|
| Also known as | Solosa, Amaryl |
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. (PHASE3)
- Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure (PHASE3)
- Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients (NA)
- Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh (PHASE4)
- Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg (PHASE1)
- Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg (PHASE1)
- Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride (NA)
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glimepiride 2 mg CI brief — competitive landscape report
- Glimepiride 2 mg updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI
Frequently asked questions about Glimepiride 2 mg
What is Glimepiride 2 mg?
Who makes Glimepiride 2 mg?
Is Glimepiride 2 mg also known as anything else?
What development phase is Glimepiride 2 mg in?
Related
- Manufacturer: Merck Sharp & Dohme LLC — full pipeline
- Also known as: Solosa, Amaryl
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing